The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.
It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.
In PNAS this week: decreased DOCK4 expression in myelodysplastic syndromes plus anemia, hepatitis A evolution, and more.
A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.
Following a beta evaluation of the system, a virology lab in Sheffield, UK, ran a workflow assessment and found improvements with the system.
The hepatitis C virus test has been approved for both the confirmation of active infection as well as for viral load monitoring.
The tests are the first assays approved by the FDA to run on the firm's Cobas 6800 and Cobas 8800 systems.
The study demonstrated the efficacy of using the Oxford Nanopore MinIon and a bespoke computational pipeline to perform metagenomics testing of viral infections in patients.
Researchers found a handful of individuals whose post-transfusion blood samples contained a new virus resembling hepaciviruses and pegiviruses.
The new test will also be packaged as a kit for routine diagnosis of HDV RNA and HBV DNA.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.